Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.89B | 6.25B | 4.72B | 6.67B | 13.85B | 11.86B |
Gross Profit | 50.08M | 171.10M | -654.33M | -717.79M | -8.82B | -3.28B |
EBITDA | -387.66M | -197.75M | -1.36B | -1.19B | -5.32B | -3.05B |
Net Income | -777.10M | -562.80M | -1.68B | -1.63B | -5.77B | -3.69B |
Balance Sheet | ||||||
Total Assets | 22.88B | 23.63B | 23.37B | 19.44B | 28.95B | 43.88B |
Cash, Cash Equivalents and Short-Term Investments | 7.37B | 5.78B | 5.48B | 6.51B | 5.94B | 16.76B |
Total Debt | 7.63B | 7.04B | 6.50B | 5.90B | 5.86B | 9.03B |
Total Liabilities | 13.41B | 14.31B | 13.37B | 7.90B | 15.28B | 23.54B |
Stockholders Equity | 9.46B | 9.32B | 10.00B | 11.54B | 13.68B | 20.34B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -165.06M | -1.23B | -1.13B | -5.91B | 967.81M |
Operating Cash Flow | 0.00 | -143.09M | -1.17B | -1.10B | -5.86B | 979.87M |
Investing Cash Flow | 0.00 | 27.08M | 37.69M | 3.21B | 4.23B | 250.69M |
Financing Cash Flow | 0.00 | 421.64M | 465.18M | -439.08M | 264.69M | 587.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥5.31B | 4.15 | 3.35% | 4.56% | -6.52% | ||
76 Outperform | ¥6.66B | 12.36 | 2.39% | 7.60% | 37.77% | ||
73 Outperform | ¥7.77B | 10.88 | 4.49% | 0.83% | -20.99% | ||
73 Outperform | ¥9.66B | 5.44 | 3.70% | -2.30% | 16.63% | ||
73 Outperform | ¥2.61B | 6.15 | 4.56% | 9.19% | -20.14% | ||
65 Neutral | $10.85B | 15.47 | 5.22% | 1.89% | 3.09% | -26.84% | |
40 Underperform | ¥2.96B | ― | 1.58% | 32.19% | 66.31% |